In Antioquia, the problems to control Rhipicephalus microplus (Canestrini, 1888) tick infestations have spread and ranchers claim conventional treatments are no longer effective. In this study, the in vitro efficacy of commercial topical products was tested with ticks obtained from two dairy farms in Antioquia with severe repeated infestations. About 800 engorged ticks were collected directly from animals in two separate visits at the beginning and end of the same month. The adult immersion test was used, which exposed groups of 40 ticks from each collection at the recommended concentration for five commercial products and combinations for 5 min. Efficacy was determined by comparing the reproductive index (fecundity × fertility) of each treated group to that of the control group. The values of all reproductive parameters obtained with ticks from the two collection dates were very similar. Cypermethrin (150 ppm) and amitraz (208 ppm) separately showed very low efficacies of only 10–20% at one farm, and zero at the other. The combination of chlorpyrifos cypermethrin was the only product with an efficacy >50% at both farms and field observations corroborated to be still capable of eliminating infestations. Exposure to fluazuron at concentrations ranging from 0.05 to 500 ppm for 1 min reduced fertility in all groups by ≥99%, as would be expected for very susceptible strains. However, reduction of oviposition only occurred at the 500 ppm concentration. In conclusion, there is a high degree of resistance to all products tested except for fluazuron.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 52 • No. 6